Number of the records: 1  

Excess ischemic tachyarrhythmias trigger protection infarction in rats

  1. 1.
    SYSNO ASEP0546478
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleExcess ischemic tachyarrhythmias trigger protection infarction in rats
    Author(s) Neckář, Jan (FGU-C) RID, ORCID
    Alánová, Petra (FGU-C) RID, ORCID
    Olejníčková, Veronika (FGU-C) RID, ORCID, SAI
    Papoušek, František (FGU-C)
    Hejnová, L. (CZ)
    Šilhavý, Jan (FGU-C) RID, ORCID
    Behuliak, Michal (FGU-C) RID, ORCID
    Bencze, Michal (FGU-C) RID, ORCID, SAI
    Hrdlička, Jaroslav (FGU-C) ORCID, RID
    Vecka, M. (CZ)
    Jarkovská, D. (CZ)
    Švíglerová, J. (CZ)
    Mistrová, E. (CZ)
    Štengl, M. (CZ)
    Novotný, J. (CZ)
    Ošťádal, Bohuslav (FGU-C) RID, ORCID
    Pravenec, Michal (FGU-C) RID, ORCID
    Kolář, František (FGU-C) RID, ORCID, SAI
    Source TitleClinical science. - : Portland Press - ISSN 0143-5221
    Roč. 135, č. 17 (2021), s. 2143-2163
    Number of pages21 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsC-reactive protein ; heart ; metabolomics ; myocardial infarction ; remote ischemic perconditioning ; ventricular arrhythmias
    Subject RIVED - Physiology
    OECD categoryPhysiology (including cytology)
    R&D ProjectsGA18-03207S GA ČR - Czech Science Foundation (CSF)
    Method of publishingLimited access
    Institutional supportFGU-C - RVO:67985823
    UT WOS000702536100001
    EID SCOPUS85116954913
    DOI10.1042/CS20210648
    AnnotationIncreased level of C-reactive protein (CRP) is a risk factor for cardiovascular diseases, including myocardial infarction and hypertension. Here, we analyzed the effects of CRP overexpression on cardiac susceptibility to ischemia/reperfusion (I/R) injury in adult spontaneously hypertensive rats (SHR) expressing human CRP transgene (SHR-CRP). Using an in vivo model of coronary artery occlusion, we found that transgenic expression of CRP predisposed SHR-CRP to repeated and prolonged ventricular tachyarrhythmias. Excessive ischemic arrhythmias in SHR-CRP led to a significant reduction in infarct size (IS) compared with SHR. The proarrhythmic phenotype in SHR-CRP was associated with altered heart and plasma eicosanoids, myocardial composition of fatty acids (FAs) in phospholipids, and autonomic nervous system imbalance before ischemia. To explain unexpected IS-limiting effect in SHR-CRP, we performed metabolomic analysis of plasma before and after ischemia. We also determined cardiac ischemic tolerance in hearts subjected to remote ischemic perconditioning (RIPer) and in hearts ex vivo. Acute ischemia in SHR-CRP markedly increased plasma levels of multiple potent cardioprotective molecules that could reduce IS at reperfusion. RIPer provided IS-limiting effect in SHR that was comparable with myocardial infarction observed in naïve SHR-CRP. In hearts ex vivo, IS did not differ between the strains, suggesting that extra-cardiac factors play a crucial role in protection. Our study shows that transgenic expression of human CRP predisposes SHR-CRP to excess ischemic ventricular tachyarrhythmias associated with a drop of pump function that triggers myocardial salvage against lethal I/R injury likely mediated by protective substances released to blood from hypoxic organs and tissue at reperfusion.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2022
    Electronic addresshttps://doi.org/10.1042/CS20210648
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.